| Literature DB >> 27418833 |
Bo Xie1, Yingfang Hu1, Zhen Liang1, Ben Liu1, Xiangyi Zheng1, Liping Xie1.
Abstract
This meta-analysis aimed to evaluate the correlation between pesticide exposure and kidney cancer. We conducted a systematic search of the Cochrane Library, Embase, Web of Knowledge, and Medline (updated to March 1, 2015) to identify all relevant studies. References of the retrieved articles were also identified. Fixed- or random-effect models were used to summarize the estimates of relative risk (RR) with 95% confidence interval for the association between exposure of pesticide and risk of kidney cancer. The pooled RR estimate indicated that pesticide exposure might have an elevated risk for kidney cancer (RR =1.10, 95% confidence interval 1.01-1.19). In a subgroup analysis of high quality articles, we detected that pesticide exposure is a significant risk factor for kidney cancer in a subgroup analysis of case-control studies, (Newcastle-Ottawa Quality Assessment Scale score >6) (RR =1.31, 95% confidence interval 1.12-1.51). North America studies, odds ratio studies, and studies with effect estimate adjusted for more than two confounder studies. In conclusion, pesticide exposure may be a risk factor for kidney cancer.Entities:
Keywords: epidemiology; kidney cancer; meta-analysis; pesticide exposure
Year: 2016 PMID: 27418833 PMCID: PMC4934868 DOI: 10.2147/OTT.S104334
Source DB: PubMed Journal: Onco Targets Ther ISSN: 1178-6930 Impact factor: 4.147
Characteristics of the eleven included studies
| Study | Region | Pesticide | Period | Follow-up time | Study design | Sex | Intensity level | Exposure assessment | Effect estimates | Dose–response | Variables of adjustment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Demers et al | Canada | Pentachlorophenol, tetrachlorophenol (herbicide) | 1950–1995 | 6 years | Cohort study | Male | Time people exposed to pesticide, hours | Database | SIR, RR | Yes | Age and calendar period |
| Hu et al | Canada | Herbicide and insecticide | 1994–1997 | NA | Case–control | Male/female | NA | Identical questionnaires | OR | No | Age, province, education, BMI, smoking, alcohol, and total consumption of meat |
| Jones et al | USA | Diazinon (insecticide) | 1993–1997 | 5 years | Cohort study | Male | IWLD | Identical questionnaires | RR | Yes | Age, smoking, and state |
| Kang et al | USA | Trifluralin (herbicide) | 1993–1997 | 7.43 years (mean) | Cohort study | Male/female | IWLD | Identical questionnaires | RR | Yes | Age, education, smoking, alcohol, family history of cancer in first-degree relatives, state, and the top five pesticides most highly correlated with trifluralin exposure |
| Karami et al | Central and Eastern Europe | NA | 1999–2003 | NA | Case–control | Male/female | Time people exposed to pesticide, hours | Identical questionnaires | OR | Yes | Age, sex, center, and smoking |
| Koutros et al | USA | Imazethapyr (aromatic amine) (herbicide) | 1993–1997 | Until 2004 | Cohort study | Male/female | IWLD | Identical questionnaires | RR | Yes | Age, sex, and family history of any cancer |
| Mellemgaard et al | Denmark | Insecticide | 1989–1992 | NA | Case–control | Male/female | NA | Interview | OR | No | Age, BMI, and smoking |
| Rafnsson | Iceland | γ-Hexachlorocyclohexane (insecticide) | 1962–1980 | Until 2003 | Cohort study | Male/female | NA | Database | SIR | No | NA |
| Settimi et al | Italy | NA | 1990–1992 | NA | Case–control | Male | Time people exposed to pesticide, hours | Identical questionnaires | OR | Yes | BMI |
| Wesseling et al | Costa Rica | NA | 1981–1993 | NA | Cohort study | Male/female | NA | Database | RR | No | Age |
| Wiklund and Dich | Sweden | NA | 1971–1987 | NA | Cohort study | Female | NA | Database | SIR | No | NA |
Abbreviations: BMI, body mass index; IWLD, intensity-weighted lifetime exposure days; NA, not available; OR, odds ratio; RR, relative risk; SIR, standardized incidence ratio.
Figure 1Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) flow diagram showing an overview of the study selection process.
Notes: From: Moher D, Liberati A, Tetzlaff J, Altman DG; The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRIMSA statement. PLoS Med. 2009;6(6):e1000097.30
Abbreviations: NOS, Newcastle–Ottawa Assessment Scale; OR, odds ratio; RR, relative risk; SIR, standardized incidence ratio.
Newcastle–Ottawa Assessment Scale for cohort studies and case–control studies
| Study | Selection
| Comparability
| Outcome
| Total | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Representativeness | Selection of controls | Ascertainment of exposure | Outcome not present at start | On age | On other risk factors | Assessment of outcome | Long enough follow-up | Adequacy of follow-up | ||
| Demers et al | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 8 |
| Jones et al | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 7 |
| Kang et al | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 7 |
| Koutros et al | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 7 |
| Rafnsson | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 6 |
| Wesseling et al | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 6 |
| Wiklund and Dich | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 5 |
|
| ||||||||||
|
| ||||||||||
| Hu et al | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 7 |
| Karami et al | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 8 |
| Mellemgaard et al | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 8 |
| Settimi et al | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 7 |
Figure 2Forest plots depicting the risk estimates from included studies on the association between pesticide exposure and risk of kidney cancer.
Abbreviations: CI, confidence interval; df, degrees of freedom; IV, inverse variance; SE, standard error.
Figure 3Funnel plots of overall analysis of relationship between pesticide exposure and kidney cancer.
Abbreviations: RR, relative risk; SE, standard error.
Subgroup meta-analysis by various study characteristics
| Subgroup | Number of studies | RR (95% CI) | Heterogeneity
| ||
|---|---|---|---|---|---|
| Herbicide | 4 | 1.22 (0.96–1.54) | 0.1 | 0.05 | 50 |
| Insecticide | 4 | 1.46 (1.32–1.86) | 0.05 | <0.01 | 78 |
| Cohort | 7 | 0.93 (0.79–1.09) | 0.36 | 0.1 | 34 |
| Case–control | 4 | 1.49 (1.23–1.8) | <0.01 | 0.14 | 33 |
| Male | 7 | 1.26 (0.94–1.69) | 0.12 | <0.01 | 81 |
| Female | 5 | 1.01 (0.76–1.35) | 0.92 | 0.09 | 46 |
| Europe | 5 | 1.15 (0.82–1.6) | 0.42 | 0.01 | 57 |
| North America | 4 | 1.31 (1.09–1.59) | <0.01 | 0.03 | 49 |
| RR | 4 | 1.04 (0.83–1.3) | 0.74 | 0.44 | 0 |
| OR | 4 | 1.49 (1.23–1.8) | <0.01 | 0.14 | 33 |
| SIR | 3 | 0.85 (0.68–1.08) | 0.18 | 0.03 | 66 |
| Questionnaires | 6 | 1.29 (1.09–1.53) | <0.01 | 0.07 | 38 |
| Database | 4 | 0.85 (0.7–1.04) | 0.11 | 0.07 | 51 |
Abbreviations: CI, confidence interval; OR, odds ratio; RR, relative risk; SIR, standardized incidence ratio.